JPRN-UMIN000007296已完成1 期
Safety and pharmacokinetic assessment of [11C]ketoprofen methylester in healthy volunteers - KET-1
Division of Molecular Imaging, Institute of Biomedical Research and Innovation0 个研究点目标入组 6 人开始时间: 2012年2月16日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)The subject who has a peptic ulcer. 2)The subject who has blood abnormality. 3)The subject who has dysfunction in the liver / kidney. 4)The subject who has cerebrovascular disorder. 5)The subject having cardiac failure. 6)The subject with WPW or LGL syndrome, or marked bradycardia, in electrocardiogram. 7)The subject with a history of a drug or food allergy. 8)The subject who was judged by the clinical investigator to be inappropriate as a participant in this study.
研究者
相似试验
已完成
1 期
Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients.JPRN-UMIN000039925Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation Department of Surgery30
已完成
2 期
Exploratory study on efficacy and safety of [11C]ketoprofen methylester in mild Alzheimer's disease, mild cognitive impairment and healthy volunteers.JPRN-UMIN000008674Division of Molecular Imaging, Institute of Biomedical Research and Innovation15
已完成
不适用
Supralimus-Core(TM) Pharmacokinetic(PK) StudyCTRI/2009/091/000426Sahajanand Medical Technologies Pvt Ltd20
尚未招募
不适用
Comparison of the Effect of Ketorolac injection in the muscle and that at the site of wound of surgery for Pain Relief after Laparoscopic Surgery of Gall Bladder.CTRI/2020/11/028916Dr Shagufta Naaz
进行中（未招募）
1 期
A double-blinded, randomized, placebo-controlled phase I/IIa study in healthy subjects and patients with liver cirrhosis evaluating safety, pharmacokinetics and preliminary effect of single and multiple doses of GR3027.Hepatic encephalopathy (HE)EUCTR2016-003651-30-SEmecrine Cognition AB101